CDKN2A and neoplasm: Although defects in cell cycle regulators such as TP53 and CDKN2A can induce the malignant transformation of a benign tumour in a mouse model10,11, escape of cell cycle check point typically occurs during the progression from low to high-grade tumour in the patient2,12–14.